Vol. 40 No. 2 (2023): Abril
Documents

Consensus of the Chilean Society of Infectious Diseases for the management of episodes of febrile neutropenia in adults and children with cancer

Ana M. Álvarez
1Hospital San Juan de Dios
Ricardo Morales
Fundación Arturo López Pérez
Mariella Raijmakers
Hospital Barros Luco-Trudeau
Verónica Contardo
Hospital de Niños Dr. Roberto del Río
Marlon Barraza
Hospital de Niños Luis Calvo Mackenna
Mónica Lafourcade
Clínica Santa María
Luisa Durán
Clínica Alemana de Valdivia
Roberto Amador
Hospital del Salvador
Teresa Bidart
Hospital del Salvador
Ivonne Flores
Fundación Arturo López Pérez
Pilar Gambra
Clínica Santa María
Claudio González
Clínica Alemana de Valdivia
Tania López
Fundación Arturo López Pérez
Ricardo Rabagliati
Pontificia Universidad Católica de Chile
María Elena Santolaya
Hospital Dr. Luis Calvo Mackenna
Cecilia Vizcaya
Pontificia Universidad Católica de Chile
Marcela Zubieta
Hospital de Niños Dr. Exequiel González Cortés

Published 2023-04-28

How to Cite

1.
Álvarez AM, Morales R, Raijmakers M, Contardo V, Barraza M, Lafourcade M, Durán L, Amador R, Bidart T, Flores I, Gambra P, González C, López T, Rabagliati R, Santolaya ME, Vizcaya C, Zubieta M. Consensus of the Chilean Society of Infectious Diseases for the management of episodes of febrile neutropenia in adults and children with cancer. Rev. Chilena. Infectol. [Internet]. 2023 Apr. 28 [cited 2025 Nov. 23];40(2). Available from: https://revinf.cl/index.php/revinf/article/view/1826

Abstract

The Committee of Infections in Immunocompromised Patients of the Chilean Society of Infectious Diseases presents an update in the Management of febrile neutropenia in adults and children with cancer. It comes from the significant changes that occurred in recent years in the confrontation of these patients. For which a multidisciplinary task force group developed recommendations in relation to their initial handling, laboratory exams required, the initial empirical antimicrobial treatment and in front of known infectious focus, invasive fungal infections and antimicrobial prophylaxis.